Skip to main content
. 2024 Feb 20;24(2):100028. doi: 10.1016/j.clinme.2024.100028

Table 3.

Multivariable logistic regression adjusted by age, sex, comorbidity score, cause of AKI, stage of AKI and admission type for odd ratio of 30-days mortality by attainment of care quality indicators.

OR 95% CI p-value
Clinical Assessment: timely review (Yes vs No)*
Consultant review within 6 h 1.13 0.83 1.55 0.43
Medication review (dose adjustments and discontinuation within 6 h) 0.95 0.65 1.39 0.80
Fluid balance assessment (Fluid balance assessment within 6 h) 1.16 0.74 1.81 0.51
Urinalysis test recorded 0.52 0.38 0.71 <0.0001
USS renal tract [within 24 hrs (<6 h if pyelo) or any other imaging to exclude obstruction] 0.68 0.49 0.94 0.020
Blood/gas acid-base recorded 1.64 1.15 2.34 0.006
Clinical management: timely Interventions - treatment completed (Y vs N) when indicated⁎⁎
Antibiotics (Within 1 h) 0.73 0.41 1.28 0.26
IV fluids 1.17 0.42 3.22 0.77
Bladder catheterisation 1.74 0.73 4.16 0.21
Follow-up: Discharge letter - TTO - if alive at discharge (Y vs N)⁎⁎⁎
AKI mentioned on discharge letter 0.73 0.27 2.01 0.54
GP Instructions re medicine and blood tests on discharge letter 0.98 0.38 2.55 0.96
Follow-up of unresolved renal function mentioned on discharge letter 0.57 0.19 1.70 0.31

some people not included because of missing data on the variable of interest (minimum cohort n=931)

⁎⁎

people excluded mainly because ‘not-indicated’ (minimum cohort n=506)

⁎⁎⁎

people excluded if died in hospital or if ‘not-indicated’ (minimum cohort n=340)